- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02323542
Plasma Glucose Kinetics and Cereal Product Content in Slowly Digestible Starch (SDS) in Healthy Volunteers
September 13, 2017 updated by: Mondelēz International, Inc.
Plasma Glucose Kinetics Following Ingestion of Two Cereal Products With a Different Content in Slowly Digestible Starch (SDS) in Healthy Males and Females
The present study aims at investigating the effect of ingesting 2 cereal products differing by their SDS content on the kinetics of glucose in healthy volunteers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The present study will compare the effect of consuming cereal products alone on :
- the rates of appearance and disappearance of exogenous and total glucose
- the glycemic and insulinemic responses
- the postprandial GIP concentrations
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H2W1R7
- Institut de Recherches Cliniques de Montreal
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 38 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteer, male or female (half male, half female);
- Aged between 18 and 40 years old (bounds included);
- Non-smoker;
- BMI ranging between 18.5 and 25 kg/m2 (bounds included)
- Waist circumference ≤ 94 cm for men and ≤ 80 cm for women;
- Stable body weight (± 1 kg) over the 3 months preceding the experimental period;
- Systolic blood pressure between 95 and 145 mmHg and diastolic blood pressure between 50 and 85 mmHg;
- For the female subjects: use of an oral contraceptive with regular menstrual cycles;
- Subject not displaying any identified significant metabolic impairment according to the Principal Investigator;
- Sedentary or with a moderate physical activity;
- Not having given blood in the month prior to the selection and accepting not to give blood during the experimental period of the present study;
- Regularly consuming a breakfast providing more than 15% of the total daily energy intake, including at least one cereal product; adequate partitioning of macronutrient intake;
- Providing written consent for his/her participation to the study;
Exclusion Criteria:
- Subject with a severe or acute disease which should influence the results of the study and to be life-threatening for the volunteer according to the Principal Investigator;
- Subject with medical history of symptomatic vascular diseases (infarct, angina pectoris, syndrome of threat, surgery or endovascular surgery, stroke, symptomatic peripheral arteritis) which according to the investigator should interfere with the results from the study or should constitute a particular risk for the subject;
- Subject with type 1 or type 2 diabetes;
- Subject with any food allergy;
- Subject with eating disorders (e.g. anorexia nervosa & bulimia) according to the Principal Investigator;
- Subject regularly consuming more than 20 g/day of alcohol;
- Subject regularly consuming recreational drugs;
- Subject consuming regularly corticoids, anorectics, adrenergic drugs, gastric demulcent, cholesterol and/or lipid lowering medication, weight-loss drugs or other drugs or supplement that should impact glucose metabolism in the Principal Investigator's opinion;
- Pregnant or lactating women;
- Currently participating in another study or having participated in another study in the 3 months prior to the selection visit;
- Consuming large amounts of food products naturally rich in 13C.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-SDS biscuit
Biscuit with high Slowly Digestible Starch content
|
acute evaluation of the effect of ingestion of cereal products differing by their Slowly Digestible Starch content
|
Active Comparator: Low-SDS cereal product
Cereal product with low Slowly Digestible Starch content
|
acute evaluation of the effect of ingestion of cereal products differing by their Slowly Digestible Starch content
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of appearance of exogenous glucose (RaE)
Time Frame: T0 to 300 minutes
|
Postprandial kinetic of RaE
|
T0 to 300 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
iAUC RaE
Time Frame: T0 to 300 minutes
|
iAUC of RaE over selected intervals over the 300-minute postprandial period
|
T0 to 300 minutes
|
kinetics of Rate of disappearance of exogenous glucose (RdE), Rate of appearance of total glucose (RaT), Rate of disappearance of total glucose (RdT) and Endogenous glucose production (EGP)
Time Frame: T0 to 300 minutes
|
Postprandial kinetics of RdE, RaT, RdT and EGP
|
T0 to 300 minutes
|
iAUC of RdE, RaT, RdT and EGP
Time Frame: T0 to 300 minutes
|
iAUC of RdE, RaT and RdT and dAUC of EGP over selected intervals over the 300-minute postprandial period
|
T0 to 300 minutes
|
kinetics of glycemia and insulinemia
Time Frame: T-120 to 300 minutes
|
Pre- and postprandial kinetics of glycemia and insulinemia
|
T-120 to 300 minutes
|
iAUC of glycemia and insulinemia
Time Frame: T0 to 300 minutes
|
iAUC of glycemia and insulinemia over selected intervals over the 300-minute postprandial period
|
T0 to 300 minutes
|
Kinetics of plasma glucose-dependent insulinotropic peptide (GIP) concentration
Time Frame: T0 to 300 minutes
|
Postprandial kinetic of GIP
|
T0 to 300 minutes
|
iAUC of GIP
Time Frame: T0 to 300 minutes
|
iAUC of GIP over selected intervals over the 300-minute postprandial period
|
T0 to 300 minutes
|
Kinetics of plasma FFA concentration
Time Frame: T0 to 300 minutes
|
Postprandial kinetic of FFA
|
T0 to 300 minutes
|
dAUC of FFA
Time Frame: T0 to 300 minutes
|
dAUC of FFA over selected intervals over the 300-minute postprandial period
|
T0 to 300 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Remi Rabasa-Llhoret, MD, PhD, Institut de Recherches Cliniques de Montreal
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
April 1, 2016
Study Registration Dates
First Submitted
December 18, 2014
First Submitted That Met QC Criteria
December 22, 2014
First Posted (Estimate)
December 23, 2014
Study Record Updates
Last Update Posted (Actual)
September 14, 2017
Last Update Submitted That Met QC Criteria
September 13, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- KBE032
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Glucose Kinetics
-
Maastricht University Medical CenterBioActorRecruiting
-
IVI MadridTerminated
-
NIZO Food ResearchFrieslandCampinaCompleted
-
NIZO Food ResearchFrieslandCampinaCompleted
-
University Hospital, Clermont-FerrandService Biologie de la reproduction-CECOSUnknownSpermatic Parameters | Embryonic KineticsFrance
-
University of HelsinkiSamfundet Folkhälsan; Sigrid Jusélius FoundationCompletedKinetics of Alkylresorcinol MetabolitesFinland
-
University of Wisconsin, MadisonCompleted
-
Wageningen University and ResearchAAKCompleted
-
NIZO Food ResearchFrieslandCampinaCompletedProtein Digestion KineticsNetherlands
-
Southern California Institute for Research and...Vanderbilt UniversityUnknownAmputation | Energy Expenditure | Artificial Limbs | KineticsUnited States
Clinical Trials on Nutrition intervention with cereal products
-
Chalmers University of TechnologyCompletedObesity | OverweightSweden
-
Lund UniversityCompleted
-
PepsiCo Global R&DCompletedCognitive PerformanceUnited States
-
Clinical Nutrition Research Center, Illinois Institute...CompletedHealthyUnited States
-
The University of Texas Health Science Center at...The Rutgers Asian Resource Center for Minority Aging Research (RCMAR)Recruiting
-
Wageningen UniversityRecruitingBlood Pressure | Cardiometabolic HealthNetherlands
-
VTT Technical Research Centre of FinlandUniversity of Eastern FinlandCompletedSubjective Appetite and SatietyFinland
-
University of TorontoSaskatchewan Pulse Growers; Pulse CanadaCompleted
-
Unilever R&DLotus Labs Pvt. Ltd, Bangalore, India; Clumax Diagnostics, Bangalore, India; Quipu...Completed